SSC
WST icon

Syverson Strege & Co’s West Pharmaceutical WST Stock Holding History

Syverson Strege & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13
Closed -$6K – 487
2021
Q3 		$6K Buy
+13
New +$5.48K ﹤0.01% 313

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Syverson Strege & Co's WST Position: Q4 2021 in Review

Syverson Strege & Co sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 13 shares — an estimated $6K sold.

Syverson Strege & Co first reported a position in WST in Q3 2021 and held it in 1 quarter. The position peaked at $6K in Q3 2021. 729 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • Syverson Strege & Co reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Syverson Strege & Co sold 13 West Pharmaceutical shares in Q4 2021, an estimated $6K.
  • Syverson Strege & Co first reported a position in West Pharmaceutical in Q3 2021 and held it in 1 quarter.
  • Syverson Strege & Co's West Pharmaceutical position peaked at $6K in Q3 2021.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Syverson Strege & Co's 13F filing for Q4 2021, filed 19 Jan 2022.